Literature DB >> 11808926

Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.

.   

Abstract

Antimicrobial prophylaxis to prevent inhalational anthrax has been recommended for persons potentially exposed to Bacillus anthracis as a result of the recent bioterrorist attacks. During October 26-November 6, 2001, an epidemiologic evaluation to detect adverse events associated with antimicrobial prophylaxis was conducted among 8,424 postal employees who had been offered antimicrobial prophylaxis for 60 days in New Jersey (NJ), New York City (NYC), and one postal facility in the District of Columbia (DC). This report summarizes preliminary results of that evaluation, which found that few employees receiving antimicrobial prophylaxis sought medical attention for symptoms that may have been associated with anaphylaxis. Persons with exposures to B. anthracis related to the bioterrorist attacks should complete the full 60-day course of antimicrobial prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11808926

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  6 in total

1.  Fear of terrorism and preparedness in New York City 2 years after the attacks: implications for disaster planning and research.

Authors:  Joseph A Boscarino; Richard E Adams; Charles R Figley; Sandro Galea; Edna B Foa
Journal:  J Public Health Manag Pract       Date:  2006 Nov-Dec

2.  Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs.

Authors:  Zeev Altboum; Yehoshua Gozes; Ada Barnea; Avi Pass; Moshe White; David Kobiler
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.

Authors:  Johnny W Peterson; Jason E Comer; Wallace B Baze; David M Noffsinger; Autumn Wenglikowski; Kristin G Walberg; Jason Hardcastle; Jennifer Pawlik; Kathryn Bush; Joanna Taormina; Scott Moen; John Thomas; Bagram M Chatuev; Laurie Sower; Ashok K Chopra; Lawrence R Stanberry; Ritsuko Sawada; Wolfgang W Scholz; Jagadish Sircar
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

4.  Adverse events associated with prolonged antibiotic use.

Authors:  Sharon B Meropol; K Arnold Chan; Zhen Chen; Jonathan A Finkelstein; Sean Hennessy; Ebbing Lautenbach; Richard Platt; Stephanie D Schech; Deborah Shatin; Joshua P Metlay
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-05       Impact factor: 2.890

5.  Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001.

Authors:  Jennifer L Williams; Stephanie S Noviello; Kevin S Griffith; Heather Wurtzel; Jennifer Hamborsky; Joseph F Perz; Ian T Williams; James L Hadler; David L Swerdlow; Renee Ridzon
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

6.  Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.

Authors:  Colin W Shepard; Montse Soriano-Gabarro; Elizabeth R Zell; James Hayslett; Susan Lukacs; Susan Goldstein; Stephanie Factor; Joshua Jones; Renee Ridzon; Ian Williams; Nancy Rosenstein
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.